SEC Form 4/A · accession 0001144204-18-033938
AVENUE THERAPEUTICS, INC. · ATXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Lindsay A Rosenwald M.D.
Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 12, 2018 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001644963
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2018 | P | 8,666 | $4.1545 | A | 28,666 | D | |
| Common StockF1 | Jun 4, 2018 | P | 3,800 | $4.1897 | A | 32,466 | D | |
| Common StockF1 | Jun 5, 2018 | P | 8,400 | $4.2796 | A | 40,866 | D | |
| Common StockF1 | Jun 6, 2018 | P | 9,100 | $4.349 | A | 49,966 | D | |
| Common StockF1 | Jun 7, 2018 | P | 14,800 | $4.3222 | A | 64,766 | D | |
| Common StockF1 | Jun 8, 2018 | P | 5,234 | $4.3421 | A | 70,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 10,000 shares of restricted stock.